Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Doebele

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal of Bacteriology|September 1, 1994
PrlA and PrlG suppressors reduce the requirement for signal sequence recognitionA M Flower, R C Doebele, T J Silhavy
Current Cancer Drug Targets|December 15, 2011
Adding to the mix: fibroblast growth factor and platelet-derived growth factor receptor pathways as targets in non-small cell lung cancerS A Kono, L E Heasley, R C Doebele, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 29, 1998
Aberrant intermolecular disulfide bonding in a mutant HLA-DM molecule: implications for assembly, maturation, and functionR Busch, R C Doebele, E von Scheven, et al.
Current Opinion in Immunology|February 19, 2000
Accessory molecules for MHC class II peptide loadingR Busch, R C Doebele, N S Patil, et al.
Immunity|November 9, 2000
Determination of the HLA-DM interaction site on HLA-DR moleculesR C Doebele, R Busch, H M Scott, et al.
Drugs of Today (Barcelona, Spain : 1998)|April 27, 2012
Crizotinib for the treatment of patients with advanced non-small cell lung cancerD W Bowles, A J Weickhardt, R C Doebele, et al.
Drugs of Today (Barcelona, Spain : 1998)|November 14, 2019
Targeted therapies for ROS1-rearranged non-small cell lung cancerT Patil, E Simons, R Mushtaq, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 9, 1998
Novel glycosylation of HLA-DRalpha disrupts antigen presentation without altering endosomal localizationC B Guerra, R Busch, R C Doebele, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Exploratory analysis of the association of depth of response and survival in patients with metastatic non-small-cell lung cancer treated with a targeted therapy or immunotherapyC E McCoach, G M Blumenthal, L Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2018
Exploratory analysis of the association of depth of response and survival in patients with metastatic non-small-cell lung cancer treated with a targeted therapy or immunotherapyC E McCoach, G M Blumenthal, L Zhang, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of Bacteriology|September 1, 1994
PrlA and PrlG suppressors reduce the requirement for signal sequence recognitionA M Flower, R C Doebele, T J Silhavy
Current Cancer Drug Targets|December 15, 2011
Adding to the mix: fibroblast growth factor and platelet-derived growth factor receptor pathways as targets in non-small cell lung cancerS A Kono, L E Heasley, R C Doebele, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 29, 1998
Aberrant intermolecular disulfide bonding in a mutant HLA-DM molecule: implications for assembly, maturation, and functionR Busch, R C Doebele, E von Scheven, et al.
Current Opinion in Immunology|February 19, 2000
Accessory molecules for MHC class II peptide loadingR Busch, R C Doebele, N S Patil, et al.
Immunity|November 9, 2000
Determination of the HLA-DM interaction site on HLA-DR moleculesR C Doebele, R Busch, H M Scott, et al.
Drugs of Today (Barcelona, Spain : 1998)|April 27, 2012
Crizotinib for the treatment of patients with advanced non-small cell lung cancerD W Bowles, A J Weickhardt, R C Doebele, et al.
Drugs of Today (Barcelona, Spain : 1998)|November 14, 2019
Targeted therapies for ROS1-rearranged non-small cell lung cancerT Patil, E Simons, R Mushtaq, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 9, 1998
Novel glycosylation of HLA-DRalpha disrupts antigen presentation without altering endosomal localizationC B Guerra, R Busch, R C Doebele, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Exploratory analysis of the association of depth of response and survival in patients with metastatic non-small-cell lung cancer treated with a targeted therapy or immunotherapyC E McCoach, G M Blumenthal, L Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2018
Exploratory analysis of the association of depth of response and survival in patients with metastatic non-small-cell lung cancer treated with a targeted therapy or immunotherapyC E McCoach, G M Blumenthal, L Zhang, et al.
Pageof 2